Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Paronychia
ADR ID BADD_A03312
ADR Hierarchy
11      Infections and infestations
11.01      Infections - pathogen unspecified
11.01.12      Skin structures and soft tissue infections
11.01.12.001      Paronychia
23      Skin and subcutaneous tissue disorders
23.09      Skin and subcutaneous tissue infections and infestations
23.09.04      Skin and subcutaneous tissue infections NEC
23.09.04.001      Paronychia
Description A disorder characterized by an infectious process involving the soft tissues around the nail. [CTCAE] An inflammatory reaction involving the folds of the skin surrounding the fingernail. It is characterized by acute or chronic purulent, tender, and painful swellings of the tissues around the nail, caused by an abscess of the nail fold. The pathogenic yeast causing paronychia is most frequently Candida albicans. Saprophytic fungi may also be involved. The causative bacteria are usually Staphylococcus, Pseudomonas aeruginosa, or Streptococcus. (Andrews' Diseases of the Skin, 8th ed, p271) [MeSH]
MedDRA Code 10034016
MeSH ID D010304
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Felon | Infected ingrowing toe nail | Infection ingrowing toenail | Onychia | Onychia and paronychia of finger | Onychia and paronychia of toe | Paronychia | Panaritium | Whitlow | Perionychitis | Nail fold infection | Panaritium tendinosum | Paronychias
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00036Acitretin--
BADD_D00047Afatinib0.038097%
BADD_D00151Apixaban--
BADD_D00156Apremilast--
BADD_D00194Azacitidine0.000533%
BADD_D00330Cabozantinib0.001066%
BADD_D00344Canagliflozin0.000766%
BADD_D00349Capecitabine0.001598%
BADD_D00412Cephalexin0.000077%
BADD_D00422Cetuximab--
BADD_D00424Cevimeline--
BADD_D00425Cevimeline hydrochloride--
BADD_D00474Cisplatin0.000799%
BADD_D00566Dabrafenib--
BADD_D00567Dabrafenib mesylate--
BADD_D00574Dalfampridine0.005229%
BADD_D00680Dimethyl fumarate--
BADD_D00723Doxorubicin0.000533%
BADD_D00750Efinaconazole--
BADD_D00800Erlotinib0.004263%
BADD_D00858Everolimus0.001460%
BADD_D00898Finasteride0.000214%
BADD_D01008Gefitinib0.001598%
BADD_D01009Gemcitabine0.001066%
BADD_D01136Imatinib0.000533%
BADD_D01150Indinavir--
BADD_D01151Indinavir sulfate--
BADD_D01213Isotretinoin0.008209%
BADD_D01248Lapatinib0.000533%
BADD_D01418Methotrexate0.001120%
The 1th Page    1 2    Next   Last    Total 2 Pages